![[Chart]](http://ichart.europe.yahoo.com/c/0b/b/bay.de)
| | | Address: | Werk Leverkusen
Leverkusen D-51368 Germany | | Web Site: | www.bayer.com | | Index: | DAX30 | EuroSTOXX50 | STOXX50 | STOXX600 | |
Market Place(s)
: | Paris | Stockholm | Frankfurt | Milan | New York | Brussels | |
Number Of Shares
: | 826,948,000 | | Sector: | Chemicals | | Industry: | Specialist Chemistry | | Sub-Industry: | Miscellaneous (Specialist Chemicals) |
|
| | Bayer, science serving well-beingThe German company, inventor of the famous aspirin, is specialised in the fields of health, nutrition, and high-tech materials in which they offer products and services that improve the quality of human life. The group's activities are developed via three divisions.HealthCare researches, develops, manufactures, and markets drugs, care products, and diagnostic equipment in the fields of human and animal health. This division was reinforced with the 2006 buyout of the pharmaceutical company Schering, which has brought them skills and expertise in oncology and gynecology. CropScience is one of the global leaders in crop protection and production of insecticides. Finally, MaterialScience is well-known for its innovative products used in the automobile, construction, and electronics sectors, as well as for sports articles and medical equipment. These products include coatings, adhesives and sealants, polycarbonates, polyurethanes, as well as basic chemistry products. Plastic materials that we use in our daily lives.Bayer - serving human life more than insects! |
|
| ISIN: | DE0005752000 | | Reuters Code: | BAY.DE | |
Local Code
: | BAY | | Auditor: | PriceWaterhouseCoopers | | Number of employees: | 106,200 ( 31/12/2007 )
106,000 ( 31/12/2006 ) |
|
| Chairman of Supervisory Board: | Manfred Schneider | | Chairman of the Executive Board: | Werner Wenning | | Chief Financial Officer: | Klaus Kühn | | Human Resources: | Richard Pott | | Data as of 31/12/2006. |
|
| Annual report: | 26/02/2010 | | Shareholder ’s meeting: | 12/05/2010 | | Profits 1st half-year: | 29/04/2010 |
|
| Institutional investors: | 61% |
|
| | |
Year
|
2007
|
2006
|
2005
|
2004
|
2003
| |
Net Operating revenues*
| 32,385 | 28,956 | 27,383 | 29,758 | 28,567 | |
Net Profit*
| 4,711 | 1,683 | 1,597 | 603 | -1,361 | | * in million(s) of
Euro |
|
|
Year
|
2007
|
2006
|
2005
|
2004
|
2003
| |
Earnings per share*
| 5.84 | 2.22 | 2.19 | 0.83 | -1.86 | | * in
Euro |
|
| HealthCare (Health and pharmacy): | 40% | | MaterialScience (Polymers ): | 35% | | CropScience (crop protection): | 20% | | Miscellaneous: | 5% | | Sector Data as of 31/12/2007 |
|
| SALES PER GEOGRAPHIC AREA | |
| Geographic areas | | Europe: | 44% | | North America: | 25% | | Asia / Pacific: | 16% | | Rest of the World: | 15% | | Areas data as of 31/12/2007 | | Profile as of 31/12/2006.
Data provided by EuroStockCity |
|
|
|
0.44 (0.91%) 
Profile
